← Open Payments lookup

DEVINA BHASIN: Open Payments

NPI 1063607109 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,820 in 60 payments from 18 companies in 2025. Trend: 2023 $759 · 2024 $14,293 · 2025 $9,820

Speaker / faculty: $6,620Food & beverage: $1,779Travel & lodging: $1,421
CompanyPaymentsAmount
Gilead Sciences, Inc.17$8,471
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$194
Amgen Inc.3$175
Fujifilm Healthcare Americas Corporation1$154
Madrigal Pharmaceuticals4$135
Mallinckrodt Hospital Products Inc.5$124
Novo Nordisk Inc2$112
ABBVIE INC.1$107
TriSalus Life Sciences, Inc.3$69
Ipsen Biopharmaceuticals, Inc2$48

Products named: Livdelzi, XIFAXAN, UTASWAKO AFP-L3, REZDIFFRA, TERLIVAZ, MAVYRET, TRINAV INFUSION SYSTEM, IQIRVO.

Industry payments across GA — which companies pay providers there.